{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:51:20Z","timestamp":1785523880663,"version":"3.56.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Fund of Zhejiang Province","award":["LZ26H060002"],"award-info":[{"award-number":["LZ26H060002"]}]},{"name":"National Natural Science Foundation of China Excellent Young Scientists Fund","award":["82422044"],"award-info":[{"award-number":["82422044"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272522"],"award-info":[{"award-number":["82272522"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12466-7","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:26:44Z","timestamp":1785227204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RNA cytosine modifications regulates musculoskeletal disorders"],"prefix":"10.1007","volume":"53","author":[{"given":"Haitao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peirui","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"issue":"4","key":"12466_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.2486\/indhealth.2016-0191","volume":"55","author":"M G\u00f3mez-Gal\u00e1n","year":"2017","unstructured":"G\u00f3mez-Gal\u00e1n M et al (2017) Musculoskeletal disorders: OWAS review. Ind Health 55(4):314\u2013337","journal-title":"Ind Health"},{"issue":"11","key":"12466_CR2","first-page":"1283","volume":"34","author":"Z Duowei","year":"2025","unstructured":"Duowei Z et al (2025) Analysis on the burden and trend of musculoskeletal diseases in China based on GBD 2021. Chin J Pharmacoepidemiology 34(11):1283\u20131293","journal-title":"Chin J Pharmacoepidemiology"},{"issue":"5","key":"12466_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2471\/BLT.17.204891","volume":"96","author":"AM Briggs","year":"2018","unstructured":"Briggs AM et al (2018) Reducing the global burden of musculoskeletal conditions. Bull World Health Organ 96(5):366\u2013368","journal-title":"Bull World Health Organ"},{"issue":"1","key":"12466_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-024-01777-5","volume":"9","author":"WW Liu","year":"2024","unstructured":"Liu WW et al (2024) RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy. Signal Transduct Target Ther 9(1):70","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"12466_CR5","doi-asserted-by":"publisher","first-page":"e001927","DOI":"10.1161\/CIRCGEN.118.001927","volume":"11","author":"A Gatsiou","year":"2018","unstructured":"Gatsiou A, Stellos K (2018) Dawn of Epitranscriptomic Medicine. Circ Genom Precis Med 11(9):e001927","journal-title":"Circ Genom Precis Med"},{"issue":"2","key":"12466_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/genes10020102","volume":"10","author":"KE Bohnsack","year":"2019","unstructured":"Bohnsack KE, H\u00f6bartner C, Bohnsack MT (2019) Eukaryotic 5-methylcytosine (m5C) RNA methyltransferases: mechanisms, cellular functions, and links to disease. Genes 10(2):102","journal-title":"Genes"},{"issue":"8","key":"12466_CR7","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1021\/jacs.1c11985","volume":"144","author":"D Bartee","year":"2022","unstructured":"Bartee D, Nance KD, Meier JL (2022) Site-Specific Synthesis of N(4)-Acetylcytidine in RNA Reveals Physiological Duplex Stabilization. J Am Chem Soc 144(8):3487\u20133496","journal-title":"J Am Chem Soc"},{"issue":"1","key":"12466_CR8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s41467-018-03513-4","volume":"9","author":"JX Cheng","year":"2018","unstructured":"Cheng JX et al (2018) RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun 9(1):1163","journal-title":"Nat Commun"},{"key":"12466_CR9","doi-asserted-by":"publisher","first-page":"1771110","DOI":"10.3389\/fcell.2026.1771110","volume":"14","author":"Q Zhou","year":"2026","unstructured":"Zhou Q et al (2026) NSUN5 and RNA m(5)C epitranscriptomic regulation in tumor progression. Front Cell Dev Biol 14:1771110","journal-title":"Front Cell Dev Biol"},{"key":"12466_CR10","doi-asserted-by":"publisher","first-page":"153259","DOI":"10.1016\/j.bbrc.2026.153259","volume":"799","author":"X Zhong","year":"2026","unstructured":"Zhong X et al (2026) Unveiling the landscape of m5C RNA methylation in lung cancer: From molecular mechanisms to therapeutic opportunities. Biochem Biophys Res Commun 799:153259","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"12466_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1261\/rna.079948.124","volume":"30","author":"S Schiffers","year":"2024","unstructured":"Schiffers S, Oberdoerffer S (2024) ac4C: a fragile modification with stabilizing functions in RNA metabolism. RNA 30(5):583\u2013594","journal-title":"RNA"},{"issue":"1","key":"12466_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12967-026-07788-w","volume":"24","author":"Y Yang","year":"2026","unstructured":"Yang Y et al (2026) NAT10 and ac4C modification in cancer immunity and metabolism: emerging mechanisms and therapeutic potential. J Transl Med 24(1):405","journal-title":"J Transl Med"},{"issue":"1","key":"12466_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41392-022-01175-9","volume":"7","author":"L Cui","year":"2022","unstructured":"Cui L et al (2022) RNA modifications: importance in immune cell biology and related diseases. Signal Transduct Target Ther 7(1):334","journal-title":"Signal Transduct Target Ther"},{"key":"12466_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molimm.2025.12.015","volume":"190","author":"C He","year":"2026","unstructured":"He C et al (2026) NSUN2 aggravates M1 macrophage polarization in arthritis progression through m5C modification of CCL2. Mol Immunol 190:45\u201355","journal-title":"Mol Immunol"},{"key":"12466_CR15","doi-asserted-by":"publisher","first-page":"1352946","DOI":"10.3389\/fimmu.2024.1352946","volume":"15","author":"M Luo","year":"2024","unstructured":"Luo M et al (2024) Macrophage polarization: an important role in inflammatory diseases. Front Immunol 15:1352946","journal-title":"Front Immunol"},{"key":"12466_CR16","doi-asserted-by":"crossref","unstructured":"Chen Y et al (2025) NSUN2 promotes osteosarcoma metastasis via stabilizing UBE2S mRNA in an m5C-dependent manner. Cell Signal 136:112065","DOI":"10.1016\/j.cellsig.2025.112065"},{"key":"12466_CR17","doi-asserted-by":"crossref","unstructured":"Hu Y et al (2025) m5C modification of LINC01082 inhibits osteosarcoma progression by modulating the miR-543-TNRC6A axis. Translational Oncol 61:102502","DOI":"10.1016\/j.tranon.2025.102502"},{"key":"12466_CR18","unstructured":"Li R (2024) The role of NSUN2-mediated mRNA m5C modification in regulating invasion of rheumatoid fibroblast like synoviocytes. Int J Rheum Dis 27 (S3):e15345"},{"issue":"3","key":"12466_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/jpp\/rgae003","volume":"76","author":"Y Huang","year":"2024","unstructured":"Huang Y et al (2024) Fat mass and obesity-associated protein inhibit the pathology of rheumatoid arthritis through the NSUN2\/ SFRP1\/Wnt\/\u03b2-catenin signal axis. J Pharm Pharmacol 76(3):283\u2013294","journal-title":"J Pharm Pharmacol"},{"key":"12466_CR20","doi-asserted-by":"crossref","unstructured":"Hong H et al (2026) Afzelin alleviates osteoarthritis by suppressing pyroptosis through decreasing NSUN5-mediated NLRC4 m5C modification. Int Immunopharmacol 171:116159","DOI":"10.1016\/j.intimp.2026.116159"},{"issue":"1","key":"12466_CR21","doi-asserted-by":"publisher","first-page":"25246","DOI":"10.1038\/s41598-025-11046-2","volume":"15","author":"Z Deng","year":"2025","unstructured":"Deng Z, Zhong W (2025) CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation via NSUN5-mediated m5C modification. Sci Rep 15(1):25246","journal-title":"Sci Rep"},{"key":"12466_CR22","doi-asserted-by":"crossref","unstructured":"Luo Z et al (2026) NSUN3-mediated m5C modification of FABP5 regulates lipid droplets through autophagy to alleviate osteoarthritis progression. Cell Signal 138:112238","DOI":"10.1016\/j.cellsig.2025.112238"},{"issue":"1","key":"12466_CR23","doi-asserted-by":"publisher","first-page":"9734","DOI":"10.1038\/s41598-025-94215-7","volume":"15","author":"G Hu","year":"2025","unstructured":"Hu G et al (2025) Isoimperatorin improves osteoporosis by increasing YBX1 expression to promote BGLAP m5C modification. Sci Rep 15(1):9734","journal-title":"Sci Rep"},{"issue":"3","key":"12466_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3803\/EnM.2023.1895","volume":"39","author":"JK Nowicki","year":"2024","unstructured":"Nowicki JK, Jakubowska-Pietkiewicz E (2024) Osteocalcin: Beyond Bones. Endocrinol Metab (Seoul) 39(3):399\u2013406","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"1","key":"12466_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1186\/s13018-024-05119-7","volume":"19","author":"L Tong","year":"2025","unstructured":"Tong L et al (2025) YBX1 alleviates ferroptosis in osteoporosis via the ATF4\/FSP1 axis in an m5C manner. J Orthop Surg Res 19(1):685","journal-title":"J Orthop Surg Res"},{"key":"12466_CR26","doi-asserted-by":"crossref","unstructured":"Li YJ et al (2024) YBX1 promotes type H vessel\u2013dependent bone formation in an m5C-dependent manner. JCI Insight 9(4):e172345","DOI":"10.1172\/jci.insight.172345"},{"key":"12466_CR27","doi-asserted-by":"crossref","unstructured":"Chen S et al (2025) NAT10-mediated ac4C modification of KDM1B drives osteoarthritis progression through epigenetic suppression of SOX9. Cell Mol Life Sci 82(1):422","DOI":"10.1007\/s00018-025-05918-z"},{"issue":"1","key":"12466_CR28","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1038\/s41467-025-60037-4","volume":"16","author":"Z Mei","year":"2025","unstructured":"Mei Z et al (2025) Chondrocyte fatty acid oxidation drives osteoarthritis via SOX9 degradation and epigenetic regulation. Nat Commun 16(1):4892","journal-title":"Nat Commun"},{"issue":"9","key":"12466_CR29","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1136\/ard-2023-225343","volume":"83","author":"D Liu","year":"2024","unstructured":"Liu D et al (2024) NAT10 promotes synovial aggression by increasing the stability and translation of N4-acetylated PTX3 mRNA in rheumatoid arthritis. Ann Rheum Dis 83(9):1118\u20131131","journal-title":"Ann Rheum Dis"},{"issue":"46","key":"12466_CR30","first-page":"e04245","volume":"12","author":"H Su","year":"2025","unstructured":"Su H et al (2025) Trained Immunity Exacerbates Inflammatory Arthritis Progression via Promoting Synovial Fibroblast Ferroptotic Resistance. Advanced science (Weinheim Baden-Wurttemberg Germany) 12(46):e04245","journal-title":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"12466_CR31","doi-asserted-by":"crossref","unstructured":"Zou Y, Xie X (2024) Effect of ac4C acetyltransferase NAT10 on tumor progression via ATF4\/ASNS mediated asparagine biosynthesis in osteosarcoma. J Clin Oncol 42(23):234","DOI":"10.1200\/JCO.2024.42.23_suppl.234"},{"issue":"7692","key":"12466_CR32","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature25465","volume":"554","author":"SRV Knott","year":"2018","unstructured":"Knott SRV et al (2018) Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 554(7692):378\u2013381","journal-title":"Nature"},{"key":"12466_CR33","doi-asserted-by":"crossref","unstructured":"Yang F, Wang M (2025) Yin yang 1 protein-activated N-acetyltransferase 10 drives cell malignant progression of osteosarcoma through ac4C acetylation of integrin \u03b23. Journal of Bone Oncology 53:100701","DOI":"10.1016\/j.jbo.2025.100701"},{"key":"12466_CR34","doi-asserted-by":"crossref","unstructured":"Mei Z et al (2024) NAT10 mediated ac4C acetylation driven m6A modification via involvement of YTHDC1-LDHA\/PFKM regulates glycolysis and promotes osteosarcoma. Cell Communication Signal 22(1):51","DOI":"10.1186\/s12964-023-01321-y"},{"key":"12466_CR35","doi-asserted-by":"crossref","unstructured":"Sun H et al (2025) Excessive compression induces cartilage endplate degeneration via the Piezo1\/NAT10\/mTOR signaling axis. Osteoarthritis and Cartilage 33(4):550-562","DOI":"10.1016\/j.joca.2025.10.014"},{"key":"12466_CR36","doi-asserted-by":"crossref","unstructured":"Shao D et al (2023) DNMT1 determines osteosarcoma cell resistance to apoptosis by associatively modulating DNA and mRNA cytosine-5 methylation. FASEB J 37(12):e23284","DOI":"10.1096\/fj.202301306R"},{"key":"12466_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.omtn.2021.06.022","volume":"26","author":"W Yang","year":"2021","unstructured":"Yang W et al (2021) ac4C acetylation of RUNX2 catalyzed by NAT10 spurs osteogenesis of BMSCs and prevents ovariectomy-induced bone loss. Mol Therapy Nucleic Acids 26:135\u2013147","journal-title":"Mol Therapy Nucleic Acids"},{"key":"12466_CR38","doi-asserted-by":"publisher","first-page":"100803","DOI":"10.1016\/j.diff.2024.100803","volume":"140","author":"PN Arya","year":"2024","unstructured":"Arya PN, Saranya I, Selvamurugan N (2024) RUNX2 regulation in osteoblast differentiation: A possible therapeutic function of the lncRNA and miRNA-mediated network. Differentiation 140:100803","journal-title":"Differentiation"},{"key":"12466_CR39","doi-asserted-by":"crossref","unstructured":"Xiao D et al (2024) Mijiao formula regulates NAT10-mediated Runx2 mRNA ac4C modification to promote bone marrow mesenchymal stem cell osteogenic differentiation and improve osteoporosis in ovariectomized rats. J Ethnopharmacol 330:118191","DOI":"10.1016\/j.jep.2024.118191"},{"key":"12466_CR40","doi-asserted-by":"crossref","unstructured":"Mo X et al (2025) Nat10-mediated N4-acetylcytidine modification enhances Nfatc1 translation to exacerbate osteoclastogenesis in postmenopausal osteoporosis. Proc Natl Acad Sci USA 122(15):e2423991122","DOI":"10.1073\/pnas.2423991122"},{"issue":"1","key":"12466_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc969","volume":"3","author":"J Downward","year":"2003","unstructured":"Downward J (2003) Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3(1):11\u201322","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"12466_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10495-025-02210-0","volume":"31","author":"H Li","year":"2026","unstructured":"Li H et al (2026) Programmed cell death in osteoarthritis. Apoptosis 31(1):3","journal-title":"Apoptosis"},{"issue":"2","key":"12466_CR43","first-page":"235","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K et al (2024) Cell death Cell 187(2):235\u2013256","journal-title":"Cell death Cell"},{"key":"12466_CR44","doi-asserted-by":"crossref","unstructured":"Zhang W et al (2025) Polyethylene microplastics transported to nucleus pulposus cells via macrophages-derived exosomes, and promote intervertebral disc degeneration through NAT10\/SLC7A11 and ac4C modification. Ecotoxicology and Environmental Safety, 306:119324","DOI":"10.1016\/j.ecoenv.2025.119324"},{"key":"12466_CR45","doi-asserted-by":"crossref","unstructured":"Yu Y et al (2023) Identification and analysis of RNA-5-methylcytosine-related key genes in osteoarthritis. BMC Genomics 24(1):539","DOI":"10.1186\/s12864-023-09651-4"},{"key":"12466_CR46","doi-asserted-by":"crossref","unstructured":"Li K et al (2024) The role of m5C RNA methylation regulators in the diagnosis and immune microenvironment of osteoarthritis. Computer Methods in Biomechanics and Biomedical Engineering29(5):952-966","DOI":"10.1080\/10255842.2024.2422911"},{"key":"12466_CR47","doi-asserted-by":"crossref","unstructured":"Chen Z, Wang W, Hua Y (2023) Expression patterns of eight RNA-modified regulators correlating with immune infiltrates during the progression of osteoarthritis. Front Immunol 14:1019445","DOI":"10.3389\/fimmu.2023.1019445"},{"issue":"D1","key":"12466_CR48","doi-asserted-by":"publisher","first-page":"D196","DOI":"10.1093\/nar\/gkab1075","volume":"50","author":"J Ma","year":"2022","unstructured":"Ma J et al (2022) m5C-Atlas: a comprehensive database for decoding and annotating the 5-methylcytosine (m5C) epitranscriptome. Nucleic Acids Res 50(D1):D196\u2013d203","journal-title":"Nucleic Acids Res"},{"key":"12466_CR49","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.2147\/JIR.S431076","volume":"16","author":"H Zheng","year":"2023","unstructured":"Zheng H et al (2023) The m6A\/m1A\/m5C-Related Methylation Modification Patterns and Immune Landscapes in Rheumatoid Arthritis and Osteoarthritis Revealed by Microarray and Single-Cell Transcriptome. J Inflamm Res 16:5001\u20135025","journal-title":"J Inflamm Res"},{"issue":"1","key":"12466_CR50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12943-024-02105-9","volume":"23","author":"S Yu","year":"2024","unstructured":"Yu S, Yao X (2024) Advances on immunotherapy for osteosarcoma. Mol Cancer 23(1):192","journal-title":"Mol Cancer"},{"issue":"16","key":"12466_CR51","first-page":"5868","volume":"26","author":"ZY Wu","year":"2022","unstructured":"Wu ZY, Shi ZY (2022) The prognostic value and immune landscapes of m1A\/m5C\/m6A-associated lncRNA signature in osteosarcoma. Eur Rev Med Pharmacol Sci 26(16):5868\u20135883","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"12466_CR52","doi-asserted-by":"crossref","unstructured":"Zhang H, Xu P, Song Y (2021) Machine-Learning-Based m5C Score for the Prognosis Diagnosis of Osteosarcoma. Journal of Oncology 2021:1629318","DOI":"10.1155\/2021\/1629318"},{"issue":"1","key":"12466_CR53","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1038\/s41598-024-54197-4","volume":"14","author":"J Gao","year":"2024","unstructured":"Gao J et al (2024) Revealing the pharmacological effects of Remodelin against osteosarcoma based on network pharmacology, acRIP-seq and experimental validation. Sci Rep 14(1):3577","journal-title":"Sci Rep"},{"key":"12466_CR54","doi-asserted-by":"crossref","unstructured":"Radbakhsh S et al (2025) RNA Modifications in Osteoarthritis: Epitranscriptomic Insights into Pathogenesis and Therapeutic Targets. Int J Mol Sci 26(10):4955","DOI":"10.3390\/ijms26104955"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12466-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12466-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12466-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:29:19Z","timestamp":1785518959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12466-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12466"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12466-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"18 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"<b>Competing interests<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"<b>Consent for publication<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"<b>Ethics approval and consent to participate<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1284"}}